business

Clearances main worry, says Serum head on dengue antibody

Serum Chief executive officer Adar Poonawalla says the company has entered into an exclusive agreement with US-based Visterra for developing a dengue antibody.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Sections